Pymepharco Joint Stock Company
Pymepharco Joint Stock Company
🇻🇳 Vietnam, Dak Lak
19891001-2000 peopleManufacturer/DistributorPymepharco Joint Stock Company is a leading pharmaceutical manufacturer and distributor based in Tuy Hoa, Vietnam. Established as a subsidiary of the global STADA Group, the company has evolved from a local medical supplier into a major regional player with a workforce of over 1,000 employees. Pymepharco specializes in the production of high-quality generic pharmaceuticals, prescription drugs, and OTC medicines, with a particular focus on antibiotics such as Cephalosporin. Their extensive product portfolio includes analgesics, antipyretics, anti-inflammatory drugs, vitamins, minerals, and dietary supplements, as well as medical equipment and medicinal chemicals.
The company operates advanced manufacturing facilities, including the modern PME II factory, which features a production capacity of 1.2 billion tablets per shift annually. Pymepharco is distinguished as a pioneer in Vietnam for achieving EU-GMP standards, ensuring their injectable powders, tablets, soft and hard capsules, and granules meet international quality benchmarks. In addition to its own branded products, the company provides OEM services and maintains strategic partnerships with international firms like Enzymatica. As a key contributor to the Southeast Asian pharmaceutical supply chain, Pymepharco focuses on delivering affordable, high-quality healthcare solutions through sustainable development and advanced scientific applications.
OEM manufacturerOffers OEM services for customized brand manufacturing.
High capacity factoryCan handle large-scale or bulk production orders.
Established brandFounded in 1989, with over 20 years of industry experience.
Large enterprise groupPart of a large industrial or corporate group with 1001-2000 people.
Contact
**************
1
********************
1
Products
Pymepharco Building
Customers
MERIEUX NUTRISCIENCES
********
*****
**************
*******
Unlock all 17 customers
Certifications
GMP2
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Pharbaco Central Pharmaceutical Joint Stock Company I
🇻🇳 Vietnam
1954501-1000 peopleManufacturer/Trading Company/DistributorHigh capacity factory
Established brand
OEM manufacturer
High-tech enterprise
Shipments
118
Key customer
KKC
Key market
🇻🇳 Vietnam
Description
Pharbaco Central Pharmaceutical Joint Stock Company I is a premier pharmaceutical manufacturer and distributor based in Hanoi, Vietnam. Established in 1954, the company has a 70-year history as a cornerstone of the national pharmaceutical industry. Operating as a manufacturer, trading company, and OEM/contract manufacturer, Pharbaco maintains a workforce of 501 to 1,000 employees and manages a significant production complex in Soc Son District. The company is recognized for its extensive manufacturing capabilities, featuring modern production lines from Germany, the UK, and the US, and holds certifications including WHO-GMP, EU-GMP, GLP, and GSP.
Pharbaco offers a diverse portfolio of over 500 products across various therapeutic categories, including antibiotics (Cephalosporin, Penicillin, and Carbapenem), cardiovascular medications, anti-inflammatory drugs, vitamins, and dietary supplements. Their production facilities include specialized lines for injectable powders, oral solid dosages (OSD), and traditional medicinal herbs. Beyond pharmaceuticals, the company is involved in the supply of medical equipment, cosmetics, and specialized drugs for national health programs targeting tuberculosis and malaria.
With a strong focus on research and development, Pharbaco operates international-standard laboratories and R&D centers in Hanoi and Ho Chi Minh City. The company has a robust international trade presence, exporting high-quality Vietnamese medicines to over 20 countries and territories worldwide. Listed on the UPCOM market under the ticker PBC, Pharbaco continues to expand its scale through multi-phase factory upgrades to meet evolving global healthcare standards.
Fabafixim
Cefadroxil 250mg
Introduce | Pharbaco
Pharbaco factory
Pharbaco Building
Pharbaco Central Pharmaceutical Joint Stock Company
Mekophar Chemical Pharmaceutical Joint-Stock Company
🇻🇳 Vietnam
1975501-1000 peopleManufacturer/Trading Company/DistributorHigh capacity factory
Established brand
Own brand
Industry association member
Shipments
84
Key customer
NIPRO
Key market
🇻🇳 Vietnam
Description
Mekophar Chemical Pharmaceutical Joint-Stock Company (MEKOPHAR) is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. Established in 1975 and equitized as a joint-stock company in 2002, the organization has grown into a major industry player with a workforce of approximately 500 to 1,000 employees and an annual revenue estimated at $157.9 million. The company operates multiple production bases and a nationwide distribution network with branches in Hanoi, Da Nang, and Can Tho.
Mekophar specializes in a comprehensive range of healthcare solutions, including the manufacturing, export, and import of pharmaceuticals, herbal medicines, and oriental medicines. Its extensive product portfolio covers therapeutic areas such as antibiotics (oral and injectable), analgesics, antipyretics, cardiovascular drugs, gastrointestinal agents, and antimalarials. Beyond finished dosage forms, the company supplies pharmaceutical raw materials, medical devices, and specialized packaging solutions including plastic bottles and carton boxes.
As a vertically integrated manufacturer, Mekophar offers OEM services and maintains a focus on high-quality standards to serve both domestic and international markets. The company has also diversified its business interests into stem cell banking services through its relationship with Mekostem, as well as food technology and cosmetics. Listed on the UPCOM securities trading center under the ticker MKP, Mekophar remains a key contributor to the regional pharmaceutical sector through its commitment to safe and effective public health products.
Mekophar company building
Mekophar Logo
Mekophar Building
pharmaceuticals
